AWAG
CRMD icon

ARS Wealth Advisors Group’s CorMedix CRMD Stock Holding History

ARS Wealth Advisors Group’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,000
Closed -$108K – 192
2025
Q2 		$108K Buy
+10,000
New +$110K 0.01% 186
2023
Q2 		– Sell
-11,000
Closed -$74.7K – 142
2023
Q1 		$74.7K Sell
11,000
-1,000
-8% -$4.09K 0.01% 122
2022
Q4 		$76.8K Buy
12,000
+1,000
+9% +$3.54K 0.01% 135
2022
Q3 		$70K Buy
+11,000
New +$45.8K 0.01% 145

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ARS Wealth Advisors Group's CRMD Position: Q3 2025 in Review

ARS Wealth Advisors Group sold out of CorMedix (CRMD) in Q3 2025, closing a stake of 10,000 shares — an estimated $108K sold.

ARS Wealth Advisors Group first reported a position in CRMD in Q3 2022 and held it in 4 quarters. The position peaked at $108K in Q2 2025. 190 funds tracked by Wall St. Rank hold CRMD as of Q3 2025.

  • ARS Wealth Advisors Group reported no remaining CorMedix position as of Q3 2025 after selling out during the quarter.
  • ARS Wealth Advisors Group sold 10,000 CorMedix shares in Q3 2025, an estimated $108K.
  • ARS Wealth Advisors Group first reported a position in CorMedix in Q3 2022 and held it in 4 quarters.
  • ARS Wealth Advisors Group's CorMedix position peaked at $108K in Q2 2025.
  • 190 funds tracked by Wall St. Rank held CorMedix as of Q3 2025.

Based on ARS Wealth Advisors Group's 13F filing for Q3 2025, filed 6 Oct 2025.